Genome & Company (KOSDAQ:314130)

South Korea · Delayed Price · Currency is KRW

3,370.00

+85.00 (2.59%)

At close: Sep 9, 2026

Genome & Company Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	24,461	24,587	27,745	14,296	14,085	451.25
Revenue Growth	1.84%	-11.38%	94.07%	1.50%	3021.27%	199.67%
Gross Profit	13,331	13,406	15,670	4,064	5,598	374.24
Operating Income	-29,189	-29,234	-24,199	-55,092	-57,512	-36,087
Net Income	-41,361	-6,428	-20,112	-47,466	-51,838	-34,117
Earnings Per Share	-1179.43	-205.30	-660.00	-1680.81	-1841.50	-1269.10
EPS Growth	-	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	64,301	36,830	80,930	86,272	106,699	77,164
Total Debt	24,811	18,967	32,024	26,453	6,291	6,826
Net Cash (Debt)	39,490	17,862	48,906	59,819	100,408	70,338
Net Cash Growth	23.96%	-63.48%	-18.24%	-40.42%	42.75%	-34.77%
Net Cash Per Share	1126.06	570.49	1604.88	2118.26	3566.88	2616.46

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-17,550	-18,387	-16,331	-32,224	-43,550	-26,159
Capital Expenditures	-540.08	-284.66	-3,970	-18,853	-6,849	-2,875
Free Cash Flow	-18,090	-18,671	-20,301	-51,077	-50,399	-29,034
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	54.50%	54.53%	56.48%	28.43%	39.74%	82.94%
Operating Margin	-119.33%	-118.90%	-87.22%	-385.37%	-408.34%	-7997.20%
Pretax Margin	-182.27%	-35.25%	-101.69%	-362.72%	-412.03%	-7978.71%
Profit Margin	-169.09%	-26.14%	-72.49%	-332.02%	-368.05%	-7560.62%
FCF Margin	-73.95%	-75.94%	-73.17%	-357.28%	-357.83%	-6434.20%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	7.21	9.70	3.07	12.33	17.46	1038.96